Two Food and Drug Administration advisory committees recently voted not to recommend approval of over-the-counter sales of lovastatin. This article reviews the rationale behind the committees' recommendations and discusses the risks and benefits of nonprescription sales of statins and other medications for asymptomatic conditions.
More...